A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ICSI / Interstitial Cystitis Symptom Index

[Related PubMed/MEDLINE]
Total Number of Papers: 46
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ICSI  (>> Co-occurring Abbreviation)
Long Form:   Interstitial Cystitis Symptom Index
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 The effect of Hydrodistension in combination with Pentosan Polysulfate on treatment outcomes and compliance in the treatment of bladder pain syndrome. BPS, FSFI, IC, ICPI, PPS, VAS
2018 A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome. CI, GRA, IC/BPS, ICPI, OR
2018 Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices. BT, HD, IC, ICPI
2018 Clinical characteristics of self-reported nocturia in patients with interstitial cystitis, and effects of bladder hydrodistention (with fulguration of Hunner lesions) on nocturia. IC, NP, VAS
2018 Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis. BPS, GAG, IC, ICPI, PST, VAS
2018 Development of novel and non-invasive diagnostic markers for lower urinary tract symptoms using urothelial cells in voided urine. Cx, IC, LUTS, TRP
2018 Early experience with topical meloxicam and lidocaine combination for the treatment of vulvodynia. ICPI
2018 Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study. BTX-A, IC/BPS, ICPI, VAS
2017 Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome. ICPI
10  2017 Childhood bladder and bowel dysfunction predicts irritable bowel syndrome phenotype in adult interstitial cystitis/bladder pain syndrome patients. BBD, BBDQ, BM, IBS, IC/BPS, ICPI, PUF
11  2017 Complete response to acupuncture therapy in female patients with refractory interstitial cystitis/bladder pain syndrome. IC/BPS, ICPI, MVV, OSS, PUF, VAS
12  2017 Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention. KAC
13  2017 Efficacy, Side Effects, and Monitoring of Oral Cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome. CyA, HLs, IC-BPS
14  2017 Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study. IC/BPS, NGF
15  2016 A Feasibility Study to Determine Whether Clinical Contrast Enhanced Magnetic Resonance Imaging can Detect Increased Bladder Permeability in Patients with Interstitial Cystitis. ICPI
16  2016 A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome. ICPI
17  2016 Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: ARelook at the Role of Cystoscopy. ---
18  2016 Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies. BPS/IC, BTX-A, CI, ICPI, MCC, PVR, RCTs, WMD
19  2016 Microvascular Injury in Ketamine-Induced Bladder Dysfunction. BM, CBC, CD31, EM, FSP-1, ICPI, KC, NMDAR1, PLA
20  2016 Pain and Urinary Symptoms Should Not be Combined into a Single Score: Psychometric Findings from the MAPP Research Network. ICPI
21  2016 Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome. CI, CS, HA, MD, VAS
22  2015 Prevalence of lower urinary tract symptoms and level of quality of life in men and women with chronic pelvic pain. CPPS, MPQ-DLV, MW-U, NIH-CPSI, PDI, PUF
23  2015 Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study. CS, GAG, HA, ICPI, PCa
24  2015 The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review. HA, ISPI, PBS/IC
25  2014 Adding a sexual dysfunction domain to UPOINT system improves association with symptoms in women with interstitial cystitis and bladder pain syndrome. FSFI, IC-BPS, UPOINT
26  2014 Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution. HA, IC/BPS, ICPI, VAS
27  2014 Clinical comparision of intravesical hyaluronic acid and hyaluronic acid-chondroitin sulphate therapy for patients with bladder pain syndrome/interstitital cystitis. BPS/IC, GAG, HA, HA-CS, ICPI, PST, VAS
28  2014 Multiple sensitivity phenotype in interstitial cystitis/bladder pain syndrome. IC/BPS, PUF, UPOINT
29  2014 Pretreatment features to influence effectiveness of intravesical hyaluronic Acid instillation in refractory interstitial cystitis/painful bladder syndrome. HA, IC/PBS, PUF, VAS
30  2013 Health-related quality of life in patients with interstitial cystitis/bladder pain syndrome and frequently associated comorbidities. CFS, FM, HRQoL, IBS, IC/BPS, MCS, PCS
31  2013 [Effectiveness of acupuncture and moxibustion therapy for the treatment of refractory interstitial cystitis]. IC, ICPI, MVV, VAS
32  2013 [Efficiency of O'Leary-Sant symptom index and problem index in the diagnosis of interstitial cystitis]. IC, ICPI, OPSI
33  2012 Contemporary management of the painful bladder: a systematic review. nRCTs, PBS/IC, RCTs, SMDs
34  2012 Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome. GRA, IC/PBS, ICPI, VAS
35  2012 Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome. IC/BPS
36  2011 Influence of smoking, coffee, and tea consumption on bladder pain syndrome in female twins. BPS, CIs, ORs
37  2011 [Experience in the treatment of interstitial cystitis: review of 17 cases]. DIMSO, IC, IC/BPS, ICPI
38  2010 Risk factors for poor sleep quality among patients with interstitial cystitis in Taiwan. HADS, NIDDK, PSQI
39  2009 Severity of interstitial cystitis symptoms and quality of life in female patients. IC, QOL, SF-36
40  2008 Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction. IC, PPS
41  2008 Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement. IC, ICPI, PPS
42  2007 Assessing urgency in interstitial cystitis/painful bladder syndrome. IC/PBS
43  2005 Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. IC, PORIS, PPS
44  2005 [The study of diagnosis and treatment of interstitial cystitis]. IC, NIDDK, PST
45  2004 Posterior tibial nerve stimulation in patients with intractable interstitial cystitis. ICPI, PPTNS
46  2001 Psychometric validation of the O'leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. IC, ICC, PORIS, PPS